This year is Milan that will host the ERS Congress, the largest meeting of respiratory professionals in the world! On Sunday 10th September the role of e-health in respiratory conditions, asthma and COPD in particular, will be discussed during a symposium that will take place at 14h45 in Session 171. The symposium will assess the wave of investment in digital health and the need for full patient involvement in the development of new tools and apps. In this context, myAirCoach is taken as a good practice and will be presented by Dr. Konstantinos Votis from CERTH.
The online magazine Evolving Science presents the very latest scientific research and forefront of engineering & technological discoveries from the world’s leading universities, research organizations and industry. In August an article about myAirCoach and its mission of enabling self-management of asthma through mobile technology was released.
In a recent video publication of the European Respiratory Society, distinguished medical researchers discuss the current difficulties and challenges in the misdiagnosis of asthma and focus specifically on the case of severe asthma as it relates to comorbidities and symptoms that significantly affect the quality of life of patients.
MyAirCoach is in a crucial stage and all partners are intensifying their efforts to deliver the innovative mHealth tool that will improve the quality of life of people with asthma. To update on all evolutions and plan the next steps, the consortium has met in Athens in June.
This year’s eHealth week took place between the 10th and the 12th of May in Malta, where more than 1,000 stakeholders gathered from four different continents. The event was an opportunity to present and share best practices in the area of the eHealth, and especially on the main theme of this year, the access to and the sharing of personal health data.
In a recent TED Ed video, professor Cristopher E. Gaw describes the main symptoms and treatments of asthma.
H&T Presspart has recently presented an new innovative design of Dry Powder Inhalers that is aiming to easier and cheaper manufacturing so as to increase the availability of inhaled medications in the developing world. The proposed design uses capsule drug cartridges, and consists of four plastic parts that are easy to manufacture. Furthermore, this innovative inhaler design promises easier and more intuitive use, supporting one of the main issues related to inhaled medication, namely the incorrect technique of patients.
MyAirCoach is committed in the same direction and has focused over the past two years in the facilitation and improvement of use for the Metered Dose Inhalers.
It is widely recognised that mobile health (mHealth) has the potential to transform the self-management of chronic diseases. For asthma, a chronic disease affecting 30 million children and adults under 45 in Europe, self-management remains a challenge due to poor inhaler technique and adherence problems.
MyAirCoach is a mobile health system that, connected to a multi-sensor based inhaler, measures not only the asthma patient condition and symptoms real-time, but also provides patients and healthcare professionals with information about the environmental factors that trigger asthma around the patient.
A myAirCoach delegation composed by CNet IHP and MyAirCoach coordinator CERTH, will attend CeBIT 2017, the largest Global Event for Digital Business that will be held in Hannover from 20th to 24th March. MyAirCoach was directly selected by the European Commission as one of the top innovator and will be featured at the EU Village at CeBIT.
News and updates regarding the event will be published during the event from the project's twitter account
To what extent physiological, behavioural and environmental data, obtained by mHealth and home-monitoring sensors, as well as patient characteristics, can be used to predict episodes of uncontrolled asthma and the onset of asthma exacerbations?
This is the aim of the observational study recently started at the clinical centres in Leiden, London and Manchester, which will involve 150 asthma patients in daily and weekly measurements.
You can read the protocol of the study here